Accuracy of the New Injury Severity Score in Evaluating Patients With Blunt Trauma
ConditionTrauma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAl-Nahrain University
About this trial
The goal of this prospective observational study is to evaluate the predictive utility of the New Injury Severity Score (NISS) in determining mortality outcomes among blunt trauma patients admitted to the Emergency Department of Kadhimiya Educational Hospital, Iraq.
The main questions it aims to answer are:
How accurately does NISS predict mortality in blunt trauma patients? What is the performance of NISS in predicting secondary outcomes, such as the need for intensive care and length of hospital stay?
Participants will:
Be assessed using the NISS score upon their admission to the emergency department.
Have their clinical outcomes, including mortality, need for intensive care, and hospital stay, monitored throughout their hospitalization.
Eligibility criteria
Qualifiers
Trauma patients admitted to the emergency department, presenting with blunt trauma, such as from motor vehicle accidents, falls, or assaults.
Patients with adequate documentation of anatomical injuries and physiological parameters required for NISS calculation.
Injury assessment and NISS calculation completed within the first 6 hours of arrival to ensure accuracy and consistency in trauma evaluation.
Disqualifiers
Patients under 18 years, pregnant women, or those with pre-existing medical conditions that may alter trauma scoring accuracy or management outcomes.
Patients presenting with medical emergencies, terminal illnesses, or conditions unrelated to blunt trauma to ensure focus on trauma-specific evaluations.
Patients declared dead on arrival or who do not receive active treatment in the emergency department.
Patients or their families refusing participation or withdrawing consent at any stage of the study.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov